JP2021511041A5 - - Google Patents
Info
- Publication number
- JP2021511041A5 JP2021511041A5 JP2020539264A JP2020539264A JP2021511041A5 JP 2021511041 A5 JP2021511041 A5 JP 2021511041A5 JP 2020539264 A JP2020539264 A JP 2020539264A JP 2020539264 A JP2020539264 A JP 2020539264A JP 2021511041 A5 JP2021511041 A5 JP 2021511041A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- antigen
- car
- treg cells
- treg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18152631 | 2018-01-19 | ||
| EP18152631.0 | 2018-01-19 | ||
| PCT/EP2019/051143 WO2019141774A1 (en) | 2018-01-19 | 2019-01-17 | Regulatory t cell expressing a chimeric antigen receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021511041A JP2021511041A (ja) | 2021-05-06 |
| JP2021511041A5 true JP2021511041A5 (enExample) | 2022-02-07 |
| JP7720148B2 JP7720148B2 (ja) | 2025-08-07 |
Family
ID=61027458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539264A Active JP7720148B2 (ja) | 2018-01-19 | 2019-01-17 | キメラ抗原受容体を発現する制御性ｔ細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12178872B2 (enExample) |
| EP (1) | EP3740569B1 (enExample) |
| JP (1) | JP7720148B2 (enExample) |
| KR (1) | KR102795692B1 (enExample) |
| CN (1) | CN111684061B (enExample) |
| CA (1) | CA3088832A1 (enExample) |
| ES (1) | ES2960686T3 (enExample) |
| WO (1) | WO2019141774A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019141774A1 (en) | 2018-01-19 | 2019-07-25 | Miltenyi Biotec Gmbh | Regulatory t cell expressing a chimeric antigen receptor |
| AU2020333659A1 (en) * | 2019-08-16 | 2022-02-24 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Anti-CD83 chimeric antigen receptor expressing t regulatory cells |
| GB201912515D0 (en) * | 2019-08-30 | 2019-10-16 | King S College London | Engineered regulatory T cell |
| WO2021156277A1 (en) * | 2020-02-04 | 2021-08-12 | Miltenyi Biotec B.V. & Co. KG | Immune cell expressing adapter chimeric antigen receptor for sensing soluble antigens |
| WO2021183687A2 (en) | 2020-03-10 | 2021-09-16 | Cellares Corporation | Systems, devices, and methods for cell processing |
| CA3259305A1 (en) * | 2022-07-11 | 2024-01-18 | Sonoma Biotherapeutics, Inc. | RECOMBINANT CYTOKINE RECEPTORS AND METHODS OF USE |
| US12180453B2 (en) | 2023-03-21 | 2024-12-31 | Cellares Corporation | Systems, devices, and methods for electroporation within a cell processing system |
| US12399193B2 (en) | 2023-05-05 | 2025-08-26 | Cellares Corporation | Systems, devices, and methods for combined cell processes |
| EP4467155A1 (en) * | 2023-05-23 | 2024-11-27 | Fundación para la Investigación Biomédica del Hospital Gregorio Marañón (FIBHGM) | Car-thytreg cells, compositions and uses thereof in immunotherapy |
| WO2025007051A2 (en) | 2023-06-30 | 2025-01-02 | Cellares Corporation | Systems, devices, and methods for fluid transfer within an automated cell processing system |
| WO2025041064A2 (en) | 2023-08-21 | 2025-02-27 | Cellares Corporation | Systems, devices, and methods for automatic cell sorting |
| US12305156B2 (en) | 2023-08-21 | 2025-05-20 | Cellares Corporation | Systems, devices, and methods for fluid control in a cell processing system |
| US12497587B2 (en) | 2023-08-21 | 2025-12-16 | Cellares Corporation | Bioreactors and methods of their use in automatic cell processing systems |
| US12492368B2 (en) | 2024-03-11 | 2025-12-09 | Cellares Corporation | Monitoring air pressure within a cell processing system |
| WO2025202944A2 (en) | 2024-03-27 | 2025-10-02 | Cellares Corporation | Liquid level and flow rate detection within a cell processing system |
| USD1109621S1 (en) | 2024-04-15 | 2026-01-20 | Cellares Corporation | Analytical platform for biological material testing |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0211118D0 (en) * | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
| GB0420466D0 (en) | 2004-09-14 | 2004-10-20 | Cassone Antonio | Anti-glucan antibodies |
| ES2660180T3 (es) | 2007-12-07 | 2018-03-21 | Miltenyi Biotec Gmbh | Sistemas y métodos para procesamiento de células |
| DE102009040716B4 (de) * | 2009-09-10 | 2011-07-14 | Miltenyi Biotec GmbH, 51429 | Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen |
| US9233125B2 (en) | 2010-12-14 | 2016-01-12 | University Of Maryland, Baltimore | Universal anti-tag chimeric antigen receptor-expressing T cells and methods of treating cancer |
| CN102153651B (zh) | 2011-01-21 | 2012-11-14 | 厦门大学 | 抗葡聚糖单链抗体及其制备方法 |
| US20170335281A1 (en) * | 2014-03-15 | 2017-11-23 | Novartis Ag | Treatment of cancer using chimeric antigen receptor |
| CA2964958A1 (en) | 2014-10-31 | 2016-05-06 | The Trustees Of The University Of Pennsylvania | Methods and compositions for modified t cells |
| JP2018527932A (ja) | 2015-09-07 | 2018-09-27 | インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
| PL3368571T3 (pl) | 2015-10-30 | 2023-05-02 | The Regents Of The University Of California | Polipeptydy odpowiadające na transformujący czynnik wzrostu beta i sposoby ich zastosowania |
| JP7123794B2 (ja) * | 2015-12-09 | 2022-08-23 | メモリアル スローン ケタリング キャンサー センター | 免疫細胞組成物及びそれを使用する方法 |
| JP2019508036A (ja) | 2016-02-16 | 2019-03-28 | ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド | 免疫療法組成物及び方法 |
| US20190048085A1 (en) | 2016-02-25 | 2019-02-14 | Cell Medica Switzerland Ag | Modified cells for immunotherapy |
| US20170274095A1 (en) * | 2016-03-23 | 2017-09-28 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced regulatory t cells targeted to sites of inflammation with chimeric antigen receptors and expressing factors that enhance viability of pancreatic cells |
| US10617720B2 (en) * | 2016-10-20 | 2020-04-14 | Miltenyi Biotech, GmbH | Chimeric antigen receptor specific for tumor cells |
| EP3336107A1 (en) * | 2016-12-15 | 2018-06-20 | Miltenyi Biotec GmbH | Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor |
| CN107557342A (zh) | 2017-11-02 | 2018-01-09 | 广东万海细胞生物科技有限公司 | 一种CAR‑Treg 细胞的制备方法及其应用 |
| WO2019141774A1 (en) | 2018-01-19 | 2019-07-25 | Miltenyi Biotec Gmbh | Regulatory t cell expressing a chimeric antigen receptor |
| CN117693439A (zh) | 2021-07-28 | 2024-03-12 | 伊顿智能动力有限公司 | 自适应可控车辆逆变器系统和方法 |
-
2019
- 2019-01-17 WO PCT/EP2019/051143 patent/WO2019141774A1/en not_active Ceased
- 2019-01-17 KR KR1020207022067A patent/KR102795692B1/ko active Active
- 2019-01-17 JP JP2020539264A patent/JP7720148B2/ja active Active
- 2019-01-17 US US16/962,755 patent/US12178872B2/en active Active
- 2019-01-17 CA CA3088832A patent/CA3088832A1/en active Pending
- 2019-01-17 CN CN201980009304.5A patent/CN111684061B/zh active Active
- 2019-01-17 ES ES19700530T patent/ES2960686T3/es active Active
- 2019-01-17 EP EP19700530.9A patent/EP3740569B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021511041A5 (enExample) | ||
| JP7451627B2 (ja) | キメラ受容体及びその使用方法 | |
| JP7390334B2 (ja) | 細胞を培養するための方法ならびにそのためのキットおよび装置 | |
| JP7387613B2 (ja) | 神経変性疾患及び障害の治療のためのキメラ抗原受容体 | |
| AU2018281316B2 (en) | Expression of novel cell tags | |
| KR102859521B1 (ko) | 지속 치료를 위한 나노입자 조성물 | |
| JP2025032089A (ja) | 腫瘍微小環境を標的とするキメラ抗原受容体 | |
| AU2025204620A1 (en) | Chimeric antigen receptors (CARS), compositions and methods thereof | |
| JP2026021299A (ja) | Ｐｒａｍｅ陽性がんに対するｔ細胞受容体およびそれを用いた免疫療法 | |
| JP7566628B2 (ja) | キメラ抗原受容体を発現する免疫細胞 | |
| US20210169929A1 (en) | Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases | |
| JP2016520074A5 (enExample) | ||
| CN111961647A (zh) | 用于扩增细胞群的方法、试剂盒及装置 | |
| JP2018531035A6 (ja) | 細胞を培養するための方法ならびにそのためのキットおよび装置 | |
| JP2019532953A (ja) | 増強された有効性を有する免疫エフェクター細胞治療 | |
| KR20110099109A (ko) | 감염 및 종양 치료 방법 | |
| TW202206453A (zh) | 表現嵌合抗原受體之病毒特異性免疫細胞 | |
| KR20090094380A (ko) | 감염 및 종양 치료를 위한 조성물 및 방법 | |
| CN111448215A (zh) | 抗-hla-a2抗体及其使用方法 | |
| US20200268796A1 (en) | Compositions and Methods for Treating Heart Disease via Redirected T Cell Immunotherapies | |
| CN111684061A (zh) | 表达嵌合抗原受体的调节性t细胞 | |
| EP3833446A2 (en) | New car constructs comprising tnfr2 domains | |
| CN111511391A (zh) | 包含间隔区的多肽组合物 | |
| JP2020526194A (ja) | 免疫療法薬と関連する毒性を評価するためのマウスモデル | |
| JP2019513394A5 (enExample) |